ฝัง
- เผยแพร่เมื่อ 5 ก.ย. 2024
- REGISTER for our next Elmarco Talks: www.elmarco.co...
Elmarco Talks: Industrial Trends
Speaker: Dr Chris Mortimer, CEO of Hybrisan (hybrisan.com/)
Patients and clinicians are dealing with 120 million chronic wounds, annually, with prevalence increasing at an alarming rate. There is an urgent need for innovative technology to assist healing, whilst also disrupting and preventing biofilm.
Electrospun nanofibres are known to exhibit a unique structure, similar to that of the extracellular matrix (ECM), offering a similar biological function which can aid wound healing. Furthermore, nanofibres are inherently bacteriostatic and with the incorporation of antimicrobial agents, such as Hybrisans’s platform Technology ‘WoundSan®’, can disrupt and prevent biofilm. This will have a significant benefits in improving the healing of chronic wounds.
Elmarco’s unique free surface electrospinning technology produced on the Nanospider™, offers the potential to effectively demonstrate up‑scalability of robust R&D and innovation. This is absolutely critical when considering the global impact of this problem. With the right expertise, Elmarcos range of pilot and industrial production lines allows for seamless scaling from laboratory to mass production.
***
Elmarco is the industry′s first and leading supplier of industrial scale nanofiber production equipment and develops its Nanospider™ product portfolio in order to provide efficient solution for any scale of roll-to-roll manufacturing, from laboratory sample preparation to industrial high volume manufacturing.
Follow ELMARCO:
Subscribe: / elmarcocompany
Website: www.elmarco.com/
LinkedIn: / elmarco
Facebook: / elmarcosro
